Bioequivalence Study of Empagliflozin Tablet in Healthy Participants

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
A Single‐Center,Open‐Label,Randomized,Single‐Dose,Two‐Period,Two‐Sequence,Crossover Study to Assess the Bioequivalence of Test Formulation Empagliflozin Tablets with Reference Formulation Jardiance® in Chinese Healthy Adult Subjects under Fasting and Fed Conditions.
Epistemonikos ID: a8beb381010c9632231748b718f016f10549b3f9
First added on: May 21, 2024